RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 New Oral Anticoagulants and Antiplatelet Drugs
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 17
SP 32
OP 33
DO 10.1177/155989771217017
UL http://mdc.sagepub.com/content/12/17/32.abstract
AB The benefit of oral anticoagulation following acute coronary syndrome (ACS) has been demonstrated in warfarin trials, showing significant reductions in myocardial infarction and stroke at the expense of an increased risk of bleeding. The impact of oral direct thrombin inhibitors and direct factor Xa inhibitors in ACS patients has been the subject of several clinical trials.